Related Experiment Video
Updated: Feb 14, 2026
08:53
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
9.2K
Paraneoplastic Pemphigus in a 34-year-old.
Laura E Melnick1, Jenna M Beasley, Randi Kim
1New York University Health, New York.
Dermatology Online Journal
|February 16, 2018
Summary
Paraneoplastic Pemphigus (PNP) is a rare autoimmune blistering disease linked to cancer. This case highlights severe stomatitis and skin lesions in a young male patient, underscoring diagnostic and treatment challenges.
Area of Science:
- Autoimmune diseases
- Dermatology
- Oncology
Background:
- Paraneoplastic Pemphigus (PNP) is a rare, severe autoimmune blistering disease.
- It is associated with an underlying malignancy and characterized by autoantibodies targeting tumor and epithelial antigens.
Observation:
- The earliest and most consistent clinical finding in PNP is severe stomatitis.
- This case presents a 34-year-old male with severe stomatitis and lichen planus-like cutaneous lesions.
Findings:
- Diagnosis relies on direct and indirect immunofluorescence of perilesional skin.
- The pathophysiology involves autoantibodies cross-reacting with desmosomal and hemidesmosomal antigens.
Implications:
- Treatment options for PNP are limited and include glucocorticoids, immunomodulators, rituximab, and IVIG.
- Despite therapeutic interventions, the prognosis for PNP remains poor, emphasizing the need for further research.
